Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FBFQY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,817
Award facts
- Contract value 100% obligated
- $10,817.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 mL syringes valued at $10,817.21. The contract, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing and is not set-aside designated, indicating competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, serves as the prime contractor through its comprehensive pharmaceutical and medical supply portfolio. The company has demonstrated substantial capacity in fulfilling federal procurement requirements across therapeutic domains, including specialty medications and medical devices for military healthcare systems. This specific delivery order supports the DLA's medical supply chain operations, ensuring pharmaceutical product availability for defense and veteran healthcare programs. The non-set-aside, competitively awarded transaction reflects the company's capability to meet federal procurement standards and its significant role as a pharmaceutical prime vendor within the DLA's global medical procurement framework.
Quick answers
Who was awarded contract SPE2DB25FBFQY?
SPE2DB25FBFQY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FBFQY worth?
The government has obligated $10,817 on SPE2DB25FBFQY.
Is contract SPE2DB25FBFQY an order under another contract?
Yes. SPE2DB25FBFQY is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB25FBFQY competed?
The extent of competition for SPE2DB25FBFQY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award